ribavirin

Generic: ribavirin

Labeler: navinta llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name ribavirin
Generic Name ribavirin
Labeler navinta llc
Dosage Form POWDER, FOR SOLUTION
Routes
RESPIRATORY (INHALATION)
Active Ingredients

ribavirin 6 g/1

Manufacturer
Navinta LLC

Identifiers & Regulatory

Product NDC 68475-003
Product ID 68475-003_76819c30-2ece-43cf-a329-6bc3720ac870
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA207366
Listing Expiration 2026-12-31
Marketing Start 2020-04-21

Pharmacologic Class

Established (EPC)
nucleoside analog antiviral [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 68475003
Hyphenated Format 68475-003

Supplemental Identifiers

RxCUI
312818
UNII
49717AWG6K
NUI
N0000175459 N0000175466

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name ribavirin (source: ndc)
Generic Name ribavirin (source: ndc)
Application Number ANDA207366 (source: ndc)
Routes
RESPIRATORY (INHALATION)
source: ndc

Resolved Composition

Strengths
  • 6 g/1
source: ndc
Packaging
  • 4 VIAL in 1 CARTON (68475-003-04) / 1 POWDER, FOR SOLUTION in 1 VIAL
source: ndc

Packages (1)

Ingredients (1)

ribavirin (6 g/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["RESPIRATORY (INHALATION)"], "spl_id": "76819c30-2ece-43cf-a329-6bc3720ac870", "openfda": {"nui": ["N0000175459", "N0000175466"], "unii": ["49717AWG6K"], "rxcui": ["312818"], "spl_set_id": ["39723ea2-780c-4266-954a-869723b144c4"], "pharm_class_epc": ["Nucleoside Analog Antiviral [EPC]"], "manufacturer_name": ["Navinta LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "4 VIAL in 1 CARTON (68475-003-04)  / 1 POWDER, FOR SOLUTION in 1 VIAL", "package_ndc": "68475-003-04", "marketing_start_date": "20200421"}], "brand_name": "RIBAVIRIN", "product_id": "68475-003_76819c30-2ece-43cf-a329-6bc3720ac870", "dosage_form": "POWDER, FOR SOLUTION", "pharm_class": ["Nucleoside Analog Antiviral [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "68475-003", "generic_name": "ribavirin", "labeler_name": "Navinta LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "RIBAVIRIN", "active_ingredients": [{"name": "RIBAVIRIN", "strength": "6 g/1"}], "application_number": "ANDA207366", "marketing_category": "ANDA", "marketing_start_date": "20200421", "listing_expiration_date": "20261231"}